Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial
PaperCitations, authors & open-access status
Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 112 citations, 2014 year and hybrid oa status.
112
Citations
2014
Year
hybrid
OA Status